Study to Evaluate a Subcutaneous Four Months Sustained-Release Formulation of Triptorelin in Patients With Prostate Cancer
- 05 February 2025 - 1 mins read
To identify the proportion of patients remaining medically castrated (testosterone level < 50 ng/dL) on Day 240 following two administrations of a 4-month sustained-release (SR) formulation of triptorelin.
05 February 2025
1 mins read
Which is the Best Dose of Dysport in Helping With Hip Pain for Children With Cerebral Palsy?
05 February 2025
1 mins read
Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression
05 February 2025
1 mins read
Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder
05 February 2025
1 mins read
Dysport® Pediatric Lower Limb Spasticity Follow-on Study
05 February 2025
1 mins read
Dysport® Adult Lower Limb Spasticity Follow-on Study
05 February 2025
1 mins read
Dysport® Pediatric Lower Limb Spasticity Study
05 February 2025
1 mins read
Dysport® Adult Lower Limb Spasticity Study
05 February 2025
1 mins read
Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines
05 February 2025
1 mins read
Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines
05 February 2025
1 mins read